Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer

AIM: To investigate second-line chemotherapy in gemcitabine-pretreated patients with advanced or metastatic pancreatic cancer [(frequency, response, outcome, course of carbohydrate antigen 19-9 (CA 19-9)]. METHODS: This retrospective study included all patients with advanced or metastatic pancreatic...

Full description

Saved in:
Bibliographic Details
Main Authors: Altwegg, Romain, Ychou, Marc, Guillaumon, Vanessa, Thezenas, Simon, Senesse, Pierre, Flori, Nicolas, Mazard, Thibault, Caillo, Ludovic, Faure, Stéphanie, Samalin, Emmanuelle, Assenat, Eric
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2012
Subjects:
Brief Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319962/
https://ncbi.nlm.nih.gov/pubmed/22493549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i12.1357
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items